Early surgical intervention may effectively treat cases of infectious keratitis that do not yield to medicine, according to Jennifer R. Rose-Nussbaumer, MD.
New systems for delivering antibiotic and anti-inflammatory drugs hold promise for cataract surgery, said Francis S. Mah, MD. Patients will benefit from not having to administer eye drops, explained Dr.
Ciclosporin A Cationic Emulsion (CsA CE; Ikervis, Santen) significantly improved signs and symptoms of dry eye disease in a randomised controlled trial.
Diabetes doubles the risk of cataract in the general population, with an even greater increased risk among people aged under 70, according to researchers.
Yvonne Buys, MD, says ophthalmologists can choose from a range of the latest devices for measuring IOP, each with its own strengths and weaknesses. While new technology continues to emerge, Dr. Buys provides an overview of tonometer technology.
Jonathan S. Myers, MD, reports that intraocular drug delivery systems could help solve the problem of poor adherence in patients taking glaucoma medications. Implanted in the eye, the systems would allow for glaucoma drugs to gradually dissolve or elute medication.
Hyper-reflective subretinal infiltrates visible on spectral domain optical coherence tomography (SD-OCT) could help diagnose primary vitreoretinal lymphoma (PVRL), researchers believe.
An artificial vision device (MyEye, OrCam) has helped a blind veteran regain his independence, according to the charity Scottish War Blinded.
Until now, surgery has been considered a second-line treatment after medication and lasers because of the risks associated with trabeculectomy and tube shunts. Now ophthalmologists can draw from a larger surgical tool chest, explains Iqbal Ike K. Ahmed, MD.
Ophthalmologists must take an active role in preventing impaired colleagues from hurting patients, according to Terri Pickering, MD.